{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:19:54Z","timestamp":1793380794971,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.mehy.2021.110753","type":"journal-article","created":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T17:26:06Z","timestamp":1641230766000},"page":"110753","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Nanomedicine formulations for respiratory infections by inhalation delivery: Covid-19 and beyond"],"prefix":"10.1016","volume":"159","author":[{"given":"Oron","family":"Zachar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.mehy.2021.110753_b0005","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3390\/molecules22081370","article-title":"Metal-based nanoparticles for the treatment of infectious diseases","volume":"22","author":"Aderibigbe","year":"2017","journal-title":"Molecules [Internet]."},{"issue":"15","key":"10.1016\/j.mehy.2021.110753_b0010","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.3390\/ijms20153620","article-title":"Synthesis and application of silver nanoparticles (Ag NPs) for the prevention of infection in healthcare workers","volume":"20","author":"Nakamura","year":"2019","journal-title":"Int J Mol Sci [Internet]"},{"issue":"1","key":"10.1016\/j.mehy.2021.110753_b0015","first-page":"9","article-title":"Could silver nano-particles control the 2019-nCoV virus?; An urgent glance to the past","volume":"3","author":"Siadati","year":"2020","journal-title":"Chem Rev Lett [Internet]"},{"issue":"10","key":"10.1016\/j.mehy.2021.110753_b0020","doi-asserted-by":"crossref","first-page":"8894","DOI":"10.3390\/molecules16108894","article-title":"Silver nanoparticles as potential antiviral agents","volume":"16","author":"Galdiero","year":"2011","journal-title":"Molecules [Internet]"},{"issue":"1","key":"10.1016\/j.mehy.2021.110753_b0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1752-153X-8-11","article-title":"Stirring time effect of silver nanoparticles prepared in glutathione mediated by green method","volume":"8","author":"Balavandy","year":"2014","journal-title":"Chem Cent J"},{"key":"10.1016\/j.mehy.2021.110753_b0030","doi-asserted-by":"crossref","first-page":"6217","DOI":"10.2147\/IJN.S214171","article-title":"Antiviral potential of green synthesized silver nanoparticles of Lampranthus coccineus and Malephora lutea","volume":"14","author":"Haggag","year":"2019","journal-title":"Int J Nanomed [Internet]"},{"issue":"6","key":"10.1016\/j.mehy.2021.110753_b0035","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1097\/ALN.0b013e3182755d7a","article-title":"Aerosolized antibiotics for ventilator-associated pneumonia: Lessons from experimental studies","volume":"117","author":"Rouby","year":"2012","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.mehy.2021.110753_b0040","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/jamp.2015.1270","article-title":"Bridging the gap between science and clinical efficacy: Physiology, imaging, and modeling of aerosols in the lung","volume":"29","author":"Darquenne","year":"2016","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"10.1016\/j.mehy.2021.110753_b0045","series-title":"Pathogenesis and immunology [Internet]","first-page":"92","author":"Behrens","year":"2006"},{"issue":"6","key":"10.1016\/j.mehy.2021.110753_b0050","doi-asserted-by":"crossref","first-page":"e225","DOI":"10.1542\/neo.15-6-e225","article-title":"Ventilator-associated pneumonia in neonates: An update","volume":"15","author":"Garland","year":"2014","journal-title":"Neoreviews [Internet]"},{"key":"10.1016\/j.mehy.2021.110753_b0055","doi-asserted-by":"crossref","unstructured":"Manjarrez-Zavala EM, Patricia D, Horacio L, Ocadiz-Delgado R, Cabello-Gutierrez C. Pathogenesis of viral respiratory infection [Internet]. In: Respiratory Disease and Infection - A New Insight. Mahboub BH (Ed.), InTech (2013) [cited 2020 Nov 30]. Available from: http:\/\/dx.doi.org\/10.5772\/54287.","DOI":"10.5772\/54287"},{"issue":"3","key":"10.1016\/j.mehy.2021.110753_b0060","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1089\/jam.2007.0603","article-title":"Estimating in vivo airway surface liquid concentration in trials of inhaled antibiotics","volume":"20","author":"Hasan","year":"2007","journal-title":"J. Aerosol Med"},{"key":"10.1016\/j.mehy.2021.110753_b0065","series-title":"Anti-infectives and the Lung","first-page":"57","author":"Ringshausen","year":"2017"},{"issue":"1","key":"10.1016\/j.mehy.2021.110753_b0070","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1477-3155-3-6","article-title":"Interaction of silver nanoparticles with HIV-1","volume":"3","author":"Elechiguerra","year":"2005","journal-title":"J. Nanobiotechnology [Internet]."},{"key":"10.1016\/j.mehy.2021.110753_b0075","doi-asserted-by":"crossref","unstructured":"Xiang D, Zheng C, Zheng Y, et al. Inhibition of A\/Human\/Hubei\/3\/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo. Int. J. Nanomedicine [Internet]. 8(1), 4103 (2013). Available from: http:\/\/dx.doi.org\/10.2147\/IJN.S53622.","DOI":"10.2147\/IJN.S53622"},{"issue":"4","key":"10.1016\/j.mehy.2021.110753_b0080","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11671-008-9128-2","article-title":"A preliminary assessment of silver nanoparticle inhibition of Monkeypox virus plaque formation","volume":"3","author":"Rogers","year":"2008","journal-title":"Nanoscale Res Lett"},{"issue":"13","key":"10.1016\/j.mehy.2021.110753_b0085","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1016\/j.biomaterials.2014.01.054","article-title":"Inhibitory effect of silver nanomaterials on transmissible virus-induced host cell infections","volume":"35","author":"Lv","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.mehy.2021.110753_b0090","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.3389\/fmicb.2016.01831","article-title":"Mechanistic basis of antimicrobial actions of silver nanoparticles","volume":"7","author":"Dakal","year":"2016","journal-title":"Front Microbiol"},{"issue":"8","key":"10.1016\/j.mehy.2021.110753_b0095","article-title":"Antiviral and immunomodulatory activity of silver nanoparticles in experimental rsv infection","volume":"11","author":"Morris","year":"2019","journal-title":"Viruses [Internet]"},{"issue":"1","key":"10.1016\/j.mehy.2021.110753_b0100","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bbrc.2003.12.081","article-title":"A model of the ACE2 structure and function as a SARS-CoV receptor","volume":"314","author":"Prabakaran","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"13","key":"10.1016\/j.mehy.2021.110753_b0105","doi-asserted-by":"crossref","first-page":"8742","DOI":"10.1039\/C6CP05562A","article-title":"Poly(vinyl alcohol) as a water protecting agent for silver nanoparticles: The role of polymer size and structure","volume":"19","author":"Kyrychenko","year":"2017","journal-title":"Phys Chem Chem Phys"},{"issue":"2","key":"10.1016\/j.mehy.2021.110753_b0110","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1183\/09031936.98.11020330","article-title":"Influence of external pH on ciliary beat frequency in human bronchi and bronchioles","volume":"11","author":"Clary-Meinesz","year":"1998","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.mehy.2021.110753_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-3155-8-1","article-title":"Mode of antiviral action of silver nanoparticles against HIV-1","volume":"8","author":"Lara","year":"2010","journal-title":"J Nanobiotechnol [Internet]"},{"issue":"8","key":"10.1016\/j.mehy.2021.110753_b0120","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s11051-008-9428-6","article-title":"Synthesis and antibacterial activity of silver nanoparticles with different sizes","volume":"10","author":"Mart\u00ednez-Casta\u00f1\u00f3n","year":"2008","journal-title":"J Nanoparticle Res [Internet]"},{"issue":"3","key":"10.1016\/j.mehy.2021.110753_b0125","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1208\/s12249-014-0092-0","article-title":"Mechanisms of pharmaceutical aerosol deposition in the respiratory tract","volume":"15","author":"Cheng","year":"2014","journal-title":"AAPS PharmSciTech [Internet]"},{"issue":"1","key":"10.1016\/j.mehy.2021.110753_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-016-1448-5","article-title":"Fundamentals of aerosol therapy in critical care","volume":"20","author":"Dhanani","year":"2016","journal-title":"Crit Care"},{"issue":"7","key":"10.1016\/j.mehy.2021.110753_b0135","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00134-010-1879-4","article-title":"Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa","volume":"36","author":"Lu","year":"2010","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.mehy.2021.110753_b0140","unstructured":"WHO. Silver in drinking-water: Background document for development of WHO Guidelines for Drinking-water Quality [Internet]. Geneva. Available from: https:\/\/www.who.int\/water_sanitation_health\/dwq\/chemicals\/silver.pdf."},{"key":"10.1016\/j.mehy.2021.110753_b0145","unstructured":"Fewtrell L. Silver: Water disinfection and toxicity [Internet]. Available from: https:\/\/www.who.int\/water_sanitation_health\/dwq\/chemicals\/Silver_water_disinfection_toxicity_2014V2.pdf."},{"issue":"2","key":"10.1016\/j.mehy.2021.110753_b0150","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/17435390.2011.648223","article-title":"Recovery from silver-nanoparticle-exposure-induced lung inflammation and lung function changes in Sprague Dawley rats","volume":"7","author":"Song","year":"2013","journal-title":"Nanotoxicology"},{"issue":"1","key":"10.1016\/j.mehy.2021.110753_b0155","doi-asserted-by":"crossref","DOI":"10.1186\/1743-8977-8-5","article-title":"Nanosilver induces minimal lung toxicity or inflammation in a subacute murine inhalation model","volume":"8","author":"Stebounova","year":"2011","journal-title":"Part Fibre Toxicol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987721002723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987721002723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:25:47Z","timestamp":1759692347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987721002723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":31,"alternative-id":["S0306987721002723"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2021.110753","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanomedicine formulations for respiratory infections by inhalation delivery: Covid-19 and beyond","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2021.110753","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110753"}}